Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface
Source abstract
Abstract
The capacity to efficiently deliver the gene-editing enzyme complex to target cells is favored over other forms of gene delivery as it offers one-time hit-and-run gene editing, thus improving precision and safety and reducing potential immunogenicity against edited cells in clinical applications. Here we performed a proof-of-mechanism study and demonstrated that a simian adenoviral vector for DNA delivery can be repurposed as a robust intracellular delivery platform for a functional Cas9/guide RNA (gRNA) complex to recipient cells. In this system, the clinically relevant adenovirus was genetically engineered with a plug-and-display technology based on SpyTag003/SpyCatcher003 coupling chemistry. Under physiological conditions, an off-the-shelf mixture of viral vector with SpyTag003 incorporated into surface capsid proteins and Cas9 fused with SpyCatcher003 led to a rapid titration reaction yielding adenovirus carrying Cas9SpyCatcher003 on the virus surface. The Cas9 fusion protein-conjugated viruses in the presence of a reporter gRNA delivered gene-editing functions to cells with an efficiency comparable to that of a commercial CRISPR/Cas9 transfection reagent. Our data fully validate the adenoviral "piggyback" approach to deliver an intracellularly acting enzyme cargo and, thus, warrant the prospect of engineering tissue-targeted adenovirus carrying Cas9/gRNA for in vivo gene editing.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: CRISPR and Genetic Engineering · RNA Interference and Gene Delivery · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Radiation Oncology, Biologic Therapeutics Center, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8224, St. Louis, Missouri 63110, United States
Funding
National Institutes of Health · Walking Fish Therapeutics
References (43)
Show source-provided references
1. 10.1038/s41579-021-00663-z10.1038/s41579-021-00663-z ↗
2. 10.3390/ijms2207332710.3390/ijms22073327 ↗
3. 10.1056/NEJMoa210745410.1056/NEJMoa2107454 ↗
4. 10.1038/s41586-021-03191-110.1038/s41586-021-03191-1 ↗
5. 10.1016/j.lfs.2021.11990810.1016/j.lfs.2021.119908 ↗
6. 10.1016/j.biomaterials.2018.04.03110.1016/j.biomaterials.2018.04.031 ↗
7. 10.1080/10717544.2018.147496410.1080/10717544.2018.1474964 ↗
8. 10.3390/v1101002810.3390/v11010028 ↗
9. 10.1038/s41467-019-12449-210.1038/s41467-019-12449-2 ↗
10. 10.3390/biom1006083910.3390/biom10060839 ↗
11. 10.1016/j.xphs.2019.10.00310.1016/j.xphs.2019.10.003 ↗
12. 10.1038/s41576-021-00439-410.1038/s41576-021-00439-4 ↗
13. 10.3390/nano1002036410.3390/nano10020364 ↗
14. 10.1021/acs.accounts.1c0052110.1021/acs.accounts.1c00521 ↗
15. 10.7150/thno.4700710.7150/thno.47007 ↗
16. 10.3389/fgene.2021.67328610.3389/fgene.2021.673286 ↗
17. 10.1038/nbt.308110.1038/nbt.3081 ↗
18. 10.1038/nbt.380610.1038/nbt.3806 ↗
19. 10.1038/s41565-019-0539-210.1038/s41565-019-0539-2 ↗
20. 10.1038/s41467-019-12906-y10.1038/s41467-019-12906-y ↗
21. 10.1038/s41467-020-17029-310.1038/s41467-020-17029-3 ↗
22. 10.1016/j.cell.2021.12.02110.1016/j.cell.2021.12.021 ↗
23. 10.1016/j.gendis.2017.04.00110.1016/j.gendis.2017.04.001 ↗
24. Dmitriev I. P. · 2016 · 23110.1016/B978-0-12-800276-6.00009-7 ↗
25. Luisoni S. · 2016 · 2710.1016/B978-0-12-800276-6.00002-4 ↗
26. 10.1016/j.coviro.2021.03.00610.1016/j.coviro.2021.03.006 ↗
27. 10.1128/JVI.01833-1310.1128/JVI.01833-13 ↗
28. 10.1002/1873-3468.1369010.1002/1873-3468.13690 ↗
29. 10.1073/pnas.88.19.885010.1073/pnas.88.19.8850 ↗
30. 10.1089/hum.1992.3.2-14710.1089/hum.1992.3.2-147 ↗
31. 10.1073/pnas.190965311610.1073/pnas.1909653116 ↗
32. 10.1038/s41591-019-0401-y10.1038/s41591-019-0401-y ↗
33. 10.1002/jgm.153010.1002/jgm.1530 ↗
34. 10.1016/j.vaccine.2017.04.06210.1016/j.vaccine.2017.04.062 ↗
35. 10.1016/j.cell.2020.08.02610.1016/j.cell.2020.08.026 ↗
36. 10.1016/j.xcrm.2021.10023010.1016/j.xcrm.2021.100230 ↗
37. 10.2217/fvl-2016-007010.2217/fvl-2016-0070 ↗
38. 10.1128/JVI.75.9.4176-4183.200110.1128/JVI.75.9.4176-4183.2001 ↗
39. 10.1089/crispr.2021.011310.1089/crispr.2021.0113 ↗
40. 10.3389/fonc.2019.0029710.3389/fonc.2019.00297 ↗
41. 10.1002/j.1460-2075.1996.tb00525.x10.1002/j.1460-2075.1996.tb00525.x ↗
42. 10.1016/j.ab.2005.11.01410.1016/j.ab.2005.11.014 ↗
43. 10.3389/fmicb.2016.0150310.3389/fmicb.2016.01503 ↗